Gunsynd

GUN · AIM · Health Care · mcap £1.7m · 0.1p

Beta Briefing, track record and signals & risks are not ready for Gunsynd yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 61 companies are already wired into a briefing: browse them.

Financials · LTM to 31 Jan 26

Source: results 26 Mar 26 ↗

Revenue: –
Operating profit: −£347k
Net income: £554k
Free cash flow: −£614k
Net cash: £563k
Market cap: £1.9m
EV / EBIT: –
FCF yield: −33.1%
Price / book: 0.7×

Latest half-year · H1 Jan 26 vs H1 Jan 25 results 26 Mar 26 ↗

Net income: £588k
Cash from operations: −£313k

Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.

As reported Key figures · multi-year

Income statement Balance sheet Cash flow

Latest interim Latest annual

Half-year Results, published 26 Mar 26 · read the announcement ↗

Consolidated statement of financial position - unaudited · As at 31 January 2026

	Unaudited At 31 January 2026 £'000	Unaudited At 31 January 2025 £'000	Audited At 31 July 2025 £'000
ASSETS
Non-current assets
Exploration assets	1,275	-	395
Financial investments	1,011	1,436	1,155
Trade and other receivables	126	-	159
Total non-current assets	2,412	1,436	1,709
Current assets
Trade and other receivables	95	264	162
Cash and cash equivalents	563	105	439
Total current assets	658	369	601
Total assets	3,070	1,805	2,310
LIABILITIES
Current liabilities
Deferred consideration	(105)	-	-
Trade and other payables	(163)	(128)	(169)
Total current liabilities	(268)	(128)	(169)
Total liabilities	(268)	(128)	(169)
Net assets	2,802	1,677	2,141
EQUITY
Equity attributable to equity holders of the company
Ordinary share capital	1,354	882	1,264
Deferred share capital	2,299	2,299	2,299
Share premium reserve	13,870	13,744	13,860
Investment in own shares	(119)	(77)	(77)
Share based payment reserve	15	-	-
Retained earnings	(14,617)	(15,171)	(15,205)
Total equity	2,802	1,677	2,141

Consolidated statement of cash flows - unaudited · For the six months ended 31 January 2026

	Unaudited Six months ended 31 January 2026 £'000	Unaudited Six months ended 31 January 2025 £'000	Audited Year ended 31 July 2025 £'000
Cash flows from operating activities
Profit/(loss) after tax	588	(357)	(391)
Finance income net of finance costs	-	(1)	(2)
Unrealised (gain)/loss on revaluation of financial investments	(682)	74	(112)
Realised (gain)/loss on sale of financial investments	(308)	(25)	(186)
Other income	-	-	-
Impairment provision	12	25	75
Shares issued in lieu of payment	-	24	79
Share based payments	15	-	-
Foreign exchange movements	1	3	(1)
Operating cash outflow before changes in working capital	(374)	(257)	(538)
Movement in trade and other receivables	67	(5)	(68)
Movement in trade and other payables	(6)	(17)	26
Cash flow from operations	(313)	(279)	(580)
Tax received	-	-	-
Net cash outflows (used in) operating activities	(313)	(279)	(580)
Cash flow from investing activities
Payments for exploration assets	(696)	-	(181)
Payments for financial investments	(20)	(130)	(220)
Disposal proceeds from sale of financial investments	1,175	129	582
Unsecured loans to investee company	-	-	10
Net cash from/(used in) investing activities	459	(1)	191
Cash flows from financing activities
Proceeds on issuing of ordinary shares	-	250	730
Cost of issue of ordinary shares	(22)	(13)	(50)
Net cash (used in)/from financing activities	(22)	237	680
Net increase/(decrease) in cash and cash equivalents	124	(43)	291
Cash and cash equivalents at start of period	439	148	148
Cash and cash equivalents at end of period	563	105	439

Final Results, published 26 Nov 25 · read the announcement ↗

STATEMENT OF COMPREHENSIVE INCOME FOR THE YEAR ENDED 31 JULY 2025

	2025 £000	2024 £000
Continuing operations
Income
Unrealised gain/(loss) on financial investments	112	(95)
Realised gain/(loss) on financial investments	186	(94)
	298	(189)
Administrative expenses
Salaries and other staff costs	(316)	(283)
Foreign exchange losses	(7)	(3)
Other administrative expenses	(322)	(306)
Total administrative expenses	(645)	(592)
Operating loss	(347)	(781)
Impairment of financial investments	(75)	(95)
Other income	29	28
Finance income	2	3
(Loss) before taxation	(391)	(845)
Taxation	-	-
(Loss) for the period attributable to equity shareholders of the Company	(391)	(845)
Other comprehensive income / (expenditure) for the period net of tax	-	-
Total comprehensive earnings for the period attributable to shareholders	(391)	(845)
Earnings per ordinary share
Basic (pence)	(0.043)	(0.171)
Diluted (pence)	(0.043)	(0.171)

STATEMENT OF FINANCIAL POSITION AS AT 31 JULY 2025

	2025 £000	2024 £000
ASSETS
Non-current assets
Exploration assets	395	-
Financial investments at fair value through profit or loss	1,155	1,295
Trade and other receivables	159	-
Total non-current assets	1,709	1,295
Current assets
Trade and other receivables	162	259
Cash and cash equivalents	439	148
Total current assets	601	407
Total assets	2,310	1,702
Current liabilities
Trade and other payables	(169)	(145)
Total current liabilities	(169)	(145)
Total liabilities	(169)	(145)
Net assets	2,141	1,557
Equity attributable to equity holders of the company
Ordinary share capital	1,264	519
Deferred share capital	2,299	2,299
Share premium reserve	13,860	13,596
Investment in own shares	(77)	(43)
Share based payments reserve	-	-
Retained earnings	(15,205)	(14,814)
Total equity	2,141	1,557

STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 JULY 2025

	2025 £000	2024 £000
Cash flow from operating activities
(Loss) after tax	(391)	(845)
Tax on losses	-	-
Finance income net of finance costs	(2)	(3)
Unrealised (gain)/ loss on revaluation of financial investments	(112)	95
Realised (gain)/loss on sale of financial investments	(186)	94
Other income	-	-
Impairment provision	75	95
Shares issued in lieu of payment	79	54
Foreign exchange movements	(1)	-
Changes in working capital
(Increase) in trade and other receivables	(68)	(62)
Increase in trade and other payables	26	41
Cash outflow from operations	(580)	(531)
Taxation received	-	-
Net cash outflow from operating activities	(580)	(531)
Cash flow from investing activities
Payments for exploration assets	(181)	-
Payments for financial investments	(220)	(475)
Disposal proceeds from sale of financial investments	582	787
Unsecured loans to investee company	10	-
Net cash inflow from investing activities	191	312
Cash flows from financing activities
Proceeds on issuing of ordinary shares	730	210
Cost of issue of ordinary shares	(50)	(7)
Net cash inflow from financing activities	680	203
Net decrease in cash and cash equivalents	291	(16)
Cash and cash equivalents at the beginning of the year	148	164
Cash and cash equivalents at the end of the year	439	148

As published in the company's results announcement: every line, heading and subtotal, read automatically from the text. Figures in brackets are negative; units as stated in the column headings.

Income statement Cash flow Balance sheet

Annual Half-yearly

Latest report: H1 Jan 26 (six months to 31 Jan 26), published 26 Mar 26 · read the results ↗

£m unless stated · newest first · italic = calculated (LTM, H2 = FY − H1) · hover a value for its source

	LTM Jan 26	FY Jul 25	FY Jul 24
Revenue to operating profit
Operating profit	–	(0.3)	(0.8)
Share-based payments	(0.0)	0.0	–
Operating profit to net income
Fair value gains / losses	1.3	0.3	–
Profit before tax	0.6	(0.4)	(0.8)
Tax	0.0	0.0	–
Net income (owners)	0.6	(0.4)	(0.8)
Per share
EPS basic	0.0p	(0.0p)	(0.2p)
EPS diluted	0.0p	(0.0p)	(0.2p)

	H1 Jan 26	vs H1 Jan 25	H2 Jul 25	H1 Jan 25
Revenue to operating profit
Share-based payments	(0.0)	n/m	0.0	0.0
Operating profit to net income
Fair value gains / losses	1.0	n/m	0.3	(0.0)
Profit before tax	0.6	n/m	(0.0)	(0.4)
Tax	0.0	n/m	0.0	0.0
Net income (owners)	0.6	n/m	(0.0)	(0.4)
Per share
EPS basic	0.0p	–	(0.0p)	(0.0p)
EPS diluted	0.0p	–	(0.0p)	(0.0p)

	LTM Jan 26	FY Jul 25	FY Jul 24
Operating activities
Cash from operations	(0.6)	(0.6)	(0.5)
Financing activities
Shares issued	0.5	0.7	0.2

	H1 Jan 26	vs H1 Jan 25	H2 Jul 25	H1 Jan 25
Operating activities
Cash from operations	(0.3)	n/m	(0.3)	(0.3)
Financing activities
Shares issued	0.0	n/m	0.5	0.2

	Latest Jan 26	FY Jul 25	FY Jul 24
Non-current assets
Other investments	1.0	1.2	–
Non-current assets	2.4	1.7	1.3
Current assets
Trade receivables	0.1	0.2	0.3
Cash	0.6	0.4	0.1
Current assets	0.7	0.6	0.4
Total assets	3.1	2.3	1.7
Current liabilities
Trade payables	0.2	0.2	0.1
Current liabilities	0.3	0.2	0.1
Non-current liabilities
Deferred consideration	0.1	0.0	–
Non-current liabilities	0.0	0.0	0.0
Total liabilities	0.3	0.2	0.1
Equity
Total equity	2.8	2.1	1.6
Net cash and other figures
Net asset value	–	2.1	1.6

	H1 Jan 26	H2 Jul 25	H1 Jan 25	H2 Jul 24
Non-current assets
Other investments	1.0	1.2	1.4	–
Non-current assets	2.4	1.7	1.4	1.3
Current assets
Trade receivables	0.1	0.2	0.3	0.3
Cash	0.6	0.4	0.1	0.1
Current assets	0.7	0.6	0.4	0.4
Total assets	3.1	2.3	1.8	1.7
Current liabilities
Trade payables	0.2	0.2	0.1	0.1
Current liabilities	0.3	0.2	0.1	0.1
Non-current liabilities
Deferred consideration	0.1	0.0	0.0	–
Non-current liabilities	0.0	0.0	0.0	0.0
Total liabilities	0.3	0.2	0.1	0.1
Equity
Total equity	2.8	2.1	1.7	1.6
Net cash and other figures
Net asset value	–	2.1	–	1.6

Line items extracted automatically from each results announcement; when a later report restates a period, the later figure is shown. LTM and H2 are calculated from reported periods. Check the source before relying on a figure.

Company filings. Not investment advice.